View Item 

Show simple item record

Brief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood‐Onset Systemic Lupus Erythematosus
dc.contributor.authorMohan, Smritien_US
dc.contributor.authorBarsalou, Julieen_US
dc.contributor.authorBradley, Timothy J.en_US
dc.contributor.authorSlorach, Cameronen_US
dc.contributor.authorReynolds, John A.en_US
dc.contributor.authorHasni, Sarfarazen_US
dc.contributor.authorThompson, Beckyen_US
dc.contributor.authorNg, Lawrenceen_US
dc.contributor.authorLevy, Deborahen_US
dc.contributor.authorSilverman, Earlen_US
dc.contributor.authorKaplan, Mariana J.en_US
dc.date.accessioned2015-08-05T16:47:45Z
dc.date.available2016-07-05T17:27:58Zen
dc.date.issued2015-05en_US
dc.identifier.citationMohan, Smriti; Barsalou, Julie; Bradley, Timothy J.; Slorach, Cameron; Reynolds, John A.; Hasni, Sarfaraz; Thompson, Becky; Ng, Lawrence; Levy, Deborah; Silverman, Earl; Kaplan, Mariana J. (2015). "Brief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood‐Onset Systemic Lupus Erythematosus." Arthritis & Rheumatology 67(8): 2257-2262.en_US
dc.identifier.issn2326-5191en_US
dc.identifier.issn2326-5205en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/112288
dc.publisherWiley Periodicals, Inc.en_US
dc.titleBrief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood‐Onset Systemic Lupus Erythematosusen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelRheumatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/112288/1/art39149.pdf
dc.identifier.doi10.1002/art.39149en_US
dc.identifier.sourceArthritis & Rheumatologyen_US
dc.identifier.citedreferenceThacker S, Berthier C, Mattinzoli D, Rastaldi MP, Kretzler M, Kaplan MJ. The detrimental effects of interferon‐α on vasculogenesis in lupus are mediated by repression of IL‐1 pathways: potential role in atherogenesis and renal vascular rarefaction. J Immunology 2010; 185: 4457 – 69.en_US
dc.identifier.citedreferenceEsdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331 – 7.en_US
dc.identifier.citedreferenceKaplan MJ. Premature vascular damage in systemic lupus erythematosus. Autoimmunity 2009; 42: 580 – 6.en_US
dc.identifier.citedreferenceStichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16: 577 – 87.en_US
dc.identifier.citedreferenceUrbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009; 54: 919 – 50.en_US
dc.identifier.citedreferenceBarsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatric‐onset rheumatological diseases. Arthritis Res Ther 2013; 15: 212.en_US
dc.identifier.citedreferenceArdoin SP, Schanberg LE, Sandborg CI, Barnhart HX, Evans GW, Yow E, et al. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis 2014; 73: 557 – 66.en_US
dc.identifier.citedreferenceRajagopalan S, Somers EC, Brook RD, Kehrer C, Pfenninger D, Lewis E, et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004; 103: 3677 – 83.en_US
dc.identifier.citedreferenceDenny M, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, et al. Interferon‐α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007; 110: 2907 – 15.en_US
dc.identifier.citedreferenceBennett L, Palucka AK, Arce E, Cantrell V, Borvak K, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711 – 23.en_US
dc.identifier.citedreferenceWerner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999 – 1007.en_US
dc.identifier.citedreferenceThacker S, Zhao W, Smith C, Luo W, Wang H, Vivekanandan‐Giri A, et al. Type I interferons modulate endothelial function, repair, thrombosis and plaque severity in murine models of lupus and atherosclerosis. Arthritis Rheum 2012; 64: 2975 – 85.en_US
dc.identifier.citedreferenceSomers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, et al. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients. PLoS One 2012; 7: e37000.en_US
dc.identifier.citedreferenceBruyndonckx L, Hoymans VY, Frederix G, De Guchtenaere A, Franckx H, Vissers DK, et al. Endothelial progenitor cells and endothelial microparticles are independent predictors of endothelial function. J Pediatr 2014; 165: 300 – 5.en_US
dc.identifier.citedreferenceHortenhuber T, Rami‐Mehar B, Satler M, Nagl K, Hobaus C, Hollerl F, et al. Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 2013; 36: 1647 – 53.en_US
dc.identifier.citedreferenceHochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.en_US
dc.identifier.citedreferencePetty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991 – 4.en_US
dc.identifier.citedreferenceBombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630 – 40.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art39149.pdf
Size:
209.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.